Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy

Neoadjuvant chemotherapy based on anthracyclines and ifosfamide for high-risk soft tissue sarcomas (STS) of the extremities and trunk is a controversial treatment option. There are substantial interindividual differences in clinical outcomes in patients treated with neoadjuvant chemotherapy. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Virgili Manrique, Anna C., Salazar, Juliana, Arranz, María Jesús, Bagué, Silvia, Orellana, Ruth, López-Pousa, Antonio, Cerdà, Paula, Gracia, Isidre, Majercakova, Katarina, Peiró, Ana, Trullols, Laura, Fernández, Manuel, Valverde, Sandra, Quintana, María Jesús, Bell, Olga, Artigas-Baleri, Alícia, Sebio, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024670/
https://www.ncbi.nlm.nih.gov/pubmed/35455734
http://dx.doi.org/10.3390/jpm12040618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024670/
https://www.ncbi.nlm.nih.gov/pubmed/35455734
http://dx.doi.org/10.3390/jpm12040618

Ejemplares similares